Clinical Trial

Factor Associated With Mortality in the ICU

Study acronym: ICUMortal
Recruiting
View on ClinicalTrials.gov →
Summary
ICU mortality indicates the severity of disease, healthcare quality, and the efficacy of interventions. The severity scores are tools to predict the risk of mortality in the ICU, and the APACHE II score is frequently used for this purpose. However, studies validating the score in Colombia are limited. There is uncertainty about the precision and discrimination capacity of the APACHE II score in a population that varies from the original, with varying diseases, and in a different timeline. The investigators determined to evaluate: 1. Evaluate the rate of mortality in the ICU by type of disease and type of admission. 2. The factors associated with mortality. 3. Validate the performance of the APACHE II score as a predictor of mortality.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-18; most recent amendment 2026-05-25.
Status change: Not Yet Recruiting → Recruiting 2026-05-25
Trial Details
NCT Number NCT07249749
Lead Sponsor Hospital Departamental de Villavicencio
Conditions Critically Ill, Intensive Care (ICU), Intensive Care Medicine, Mortality, Mortality Prediction, Mortality in Intensive Care Units
Enrollment 1,000 participants
Start Date 2026-01-10
Primary Completion 2028-12-20 (estimated)
Study Completion 2028-12-21 (estimated)
Updated on ClinicalTrials.gov 2026-05-27